Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SIMVASTATIN | 40MG | TABLET | Actual shortage | 2024-01-11 | 2024-04-18 | 215722 |
TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Actual shortage | 2024-01-11 | 2024-01-18 | 215734 |
ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-11 | 2024-05-14 | 215737 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215751 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-01-11 | 2024-01-18 | 215754 |
TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-01-11 | 2024-04-25 | 215760 |
ACT PIOGLITAZONE | 45MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-18 | 216454 |
TEVA-GLYBURIDE | 2.5MG | TABLET | Actual shortage | 2024-01-18 | 2024-02-15 | 216460 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Actual shortage | 2024-01-18 | 2024-01-25 | 216463 |
TEVA-RISEDRONATE | 30MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-19 | 216497 |
TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-25 | 2024-05-14 | 217231 |
TEVA-FENTANYL | 25MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218132 |
TEVA-FENTANYL | 50MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218137 |
TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-15 | 218940 |
TEVA-TOPILENE | 0.05% | CREAM | Actual shortage | 2024-02-08 | 2024-02-08 | 218949 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-04-18 | 218952 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Actual shortage | 2024-02-08 | 2024-03-07 | 218955 |
TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-02-08 | 2024-03-21 | 218963 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Actual shortage | 2024-02-08 | 2024-04-25 | 218977 |
TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-08 | 218980 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |